Study Title
A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patient with Central Nervous System Germinomas
Protocol ID
ACNS2321
Condition/s
Basal Ganglia Germinoma
Central Nervous System Germinoma
Diabetes Insipidus
Pineal Region Germinoma
Suprasellar Germinoma
Thalamic Germinoma
Central Nervous System Germinoma
Diabetes Insipidus
Pineal Region Germinoma
Suprasellar Germinoma
Thalamic Germinoma
Diagnosis Stage
Newly diagnosed
Location
NSW, VIC, WA, NZ
Sponsor
Children's Oncology Group
Links
Trial Status
Preparing to Open
Sites
Perth Children's Hospital
Royal Children's Hospital
Starship Children's Hospital
John Hunter Children's Hospital
Royal Children's Hospital
Starship Children's Hospital
John Hunter Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
3 to 30 years
International registry ID's
NCT06368817
| Study Title | A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patient with Central Nervous System Germinomas |
|---|---|
| Protocol ID | ACNS2321 |
| Disease (Sub Disease) | Basal Ganglia Germinoma Central Nervous System Germinoma Diabetes Insipidus Pineal Region Germinoma Suprasellar Germinoma Thalamic Germinoma |
| Diagnosis Stage | Newly diagnosed |
| Location | NSW / VIC / WA / NZ |
| Sponsor | Children's Oncology Group |
| Links | https://clinicaltrials.gov/study/NCT06368817?term=ACNS2321&rank=1 |
| Trial Status | Preparing to Open |
| Sites | Perth Children's Hospital / Royal Children's Hospital/ Starship Children's Hospital/ John Hunter Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 3 to 30 years |
| International registry ID's | NCT06368817 |